| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
50,631 |
45,572 |
$2.44M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
66,970 |
60,277 |
$1.99M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,807 |
5,652 |
$569K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,698 |
5,268 |
$496K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,704 |
4,971 |
$459K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,342 |
637 |
$394K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
109 |
94 |
$323K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,505 |
3,200 |
$257K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,888 |
3,018 |
$205K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,002 |
1,860 |
$193K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,350 |
1,220 |
$145K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,503 |
1,472 |
$145K |
| 90686 |
|
7,821 |
7,586 |
$144K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
169 |
152 |
$114K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,138 |
972 |
$97K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,151 |
1,384 |
$77K |
| 98929 |
|
961 |
754 |
$53K |
| 98928 |
|
1,240 |
1,047 |
$51K |
| 90670 |
|
2,120 |
2,047 |
$41K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
909 |
504 |
$38K |
| 36415 |
Collection of venous blood by venipuncture |
18,625 |
16,420 |
$36K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
326 |
322 |
$36K |
| 90674 |
|
1,598 |
1,565 |
$29K |
| 64615 |
|
455 |
378 |
$28K |
| 71046 |
Radiologic examination, chest; 2 views |
1,187 |
1,073 |
$25K |
| 96415 |
|
1,096 |
941 |
$24K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
618 |
532 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,173 |
2,138 |
$20K |
| 90723 |
|
1,001 |
971 |
$19K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
975 |
941 |
$19K |
| 90647 |
|
909 |
872 |
$17K |
| 73630 |
|
657 |
529 |
$15K |
| 90680 |
|
770 |
752 |
$15K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
755 |
739 |
$14K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,841 |
1,707 |
$13K |
| 95886 |
|
130 |
107 |
$12K |
| 90677 |
|
407 |
400 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
622 |
498 |
$9K |
| 92567 |
|
776 |
703 |
$9K |
| 80053 |
Comprehensive metabolic panel |
1,977 |
1,751 |
$9K |
| 92557 |
|
268 |
225 |
$6K |
| 59025 |
Fetal non-stress test |
163 |
116 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
534 |
352 |
$6K |
| 98927 |
|
152 |
136 |
$6K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
52 |
51 |
$6K |
| 69210 |
|
218 |
181 |
$5K |
| 96127 |
|
1,218 |
1,197 |
$5K |
| 0072A |
|
151 |
150 |
$5K |
| 0071A |
|
146 |
144 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,353 |
1,223 |
$5K |
| 90661 |
|
203 |
200 |
$4K |
| 0001A |
|
150 |
137 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,028 |
915 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
73 |
71 |
$4K |
| 87510 |
|
368 |
352 |
$4K |
| 87660 |
|
369 |
353 |
$4K |
| 87480 |
|
369 |
353 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
512 |
460 |
$4K |
| 0012A |
|
208 |
173 |
$4K |
| 0011A |
|
206 |
170 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
60 |
54 |
$4K |
| 0002A |
|
125 |
117 |
$4K |
| 31231 |
|
24 |
24 |
$3K |
| 97162 |
|
41 |
41 |
$3K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
21 |
20 |
$3K |
| 85652 |
|
2,000 |
1,805 |
$2K |
| 99173 |
|
764 |
752 |
$2K |
| 99215 |
Prolong outpt/office vis |
30 |
27 |
$2K |
| 99459 |
|
149 |
147 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
19 |
18 |
$2K |
| 85610 |
|
576 |
370 |
$2K |
| 85027 |
|
469 |
449 |
$2K |
| 92504 |
|
77 |
69 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
13 |
$1K |
| 86140 |
|
652 |
561 |
$1K |
| 95251 |
|
54 |
51 |
$1K |
| 20610 |
|
31 |
27 |
$1K |
| 97803 |
|
14 |
12 |
$1K |
| 31575 |
|
13 |
12 |
$1K |
| 90734 |
|
51 |
50 |
$1K |
| 90633 |
|
60 |
58 |
$1K |
| 76830 |
Ultrasound, transvaginal |
14 |
12 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
14 |
12 |
$976.59 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
70 |
70 |
$958.00 |
| 90651 |
|
45 |
45 |
$903.00 |
| 11102 |
|
16 |
12 |
$822.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
51 |
41 |
$766.66 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
79 |
73 |
$763.40 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
43 |
41 |
$679.66 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
60 |
56 |
$549.50 |
| 0054A |
|
13 |
13 |
$448.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
59 |
55 |
$432.11 |
| 0003A |
|
55 |
39 |
$396.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
160 |
140 |
$385.37 |
| 80061 |
Lipid panel |
69 |
53 |
$346.09 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13 |
13 |
$337.05 |
| 0124A |
|
13 |
12 |
$288.00 |
| 73610 |
|
16 |
12 |
$225.49 |
| 81025 |
|
28 |
24 |
$222.43 |
| 90707 |
|
14 |
12 |
$197.60 |
| 90716 |
|
14 |
12 |
$197.60 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
15 |
14 |
$192.99 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
13 |
$167.28 |
| 87210 |
|
14 |
14 |
$72.60 |
| 82570 |
|
38 |
27 |
$68.67 |
| 82043 |
|
26 |
26 |
$43.68 |
| 99441 |
|
47 |
41 |
$36.25 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
281 |
202 |
$27.51 |
| 85014 |
|
32 |
24 |
$26.99 |
| 85018 |
|
32 |
24 |
$26.99 |
| 81003 |
|
13 |
13 |
$17.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
14 |
$2.40 |
| 3078F |
|
12,387 |
11,897 |
$0.00 |
| 0502F |
|
4,750 |
3,654 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
111 |
109 |
$0.00 |
| 99442 |
|
14 |
14 |
$0.00 |
| 3074F |
|
16,202 |
15,548 |
$0.00 |
| 3079F |
|
748 |
727 |
$0.00 |
| 0501F |
|
28 |
26 |
$0.00 |
| 3075F |
|
98 |
95 |
$0.00 |
| 3044F |
|
28 |
26 |
$0.00 |
| 36416 |
|
14 |
13 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
12 |
$0.00 |